PHYZ Holdings Inc. (9325.T)
JPY 940.0
(-0.74%)
JPY 940.0
(-0.74%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 785.79 Million | 1.57 Billion | -41.55 Million | 703.37 Million | 322.67 Million | 66.52 Million |
| Net Income | 853.98 Million | 1.2 Billion | 572.43 Million | 602.12 Million | 333.49 Million | 209.73 Million |
| Depreciation & Amortization | 174.34 Million | 179.29 Million | 148.37 Million | 104.75 Million | 50.77 Million | 41.36 Million |
| Deferred income taxes | - | - | - | -209.58 Million | -18.54 Million | - |
| Stock-based compensation | - | - | - | 30.01 Million | 34.28 Million | - |
| Change in working capital | -90.86 Million | 394.63 Million | -429.52 Million | 139.38 Million | -6.66 Million | 14 Million |
| Other non-cash items | 739.98 Million | -205.66 Million | -332.83 Million | 36.68 Million | -70.68 Million | -198.58 Million |
| Investing Cash Flow | -146.36 Million | -210.38 Million | -94.41 Million | -71.38 Million | 450.97 Million | -571.23 Million |
| Investments in PPE | -159.52 Million | -80.67 Million | -19.64 Million | -62.2 Million | -26.56 Million | -90.86 Million |
| Acquisitions | 48.88 Million | 62.98 Million | -56.04 Million | -58.88 Million | 24.46 Million | -20.51 Million |
| Investment purchases | -17.7 Million | -21.08 Million | -11.09 Million | -590 Thousand | -35.15 Million | -524.35 Million |
| Sales/Maturities of investments | 49.17 Million | 33.05 Million | 6 Million | 24 Million | 504.51 Million | 35.96 Million |
| Other Investing Activities | -67.2 Million | -204.66 Million | -13.62 Million | 26.29 Million | -16.28 Million | 28.53 Million |
| Financing Cash Flow | -733.81 Million | -381.45 Million | -247.35 Million | -21.02 Million | -373.34 Million | 190.46 Million |
| Debt repayment | -260.71 Million | -428.24 Million | -228.45 Million | -475.57 Million | -215.95 Million | -181.43 Million |
| Dividends payments | -375.12 Million | -75.25 Million | - | - | -64.52 Million | - |
| Common Stock Repurchased | -33 Thousand | -26 Thousand | - | - | -99.92 Million | -59 Thousand |
| Common Stock Issuance | - | 83 Thousand | 41 Thousand | 103 Thousand | 62 Thousand | 9.08 Million |
| Other Financing Activities | -17.57 Million | 121.98 Million | -18.93 Million | 454.44 Million | 7 Million | 544.3 Million |
| Accounts receivables | -675.99 Million | 162 Million | -952 Million | -15 Million | -382 Million | -101.58 Million |
| Accounts payables | 133.02 Million | -17.28 Million | 453.12 Million | 3.7 Million | 145.65 Million | 24.86 Million |
| Inventory | - | 17.28 Million | 209.25 Million | -124.86 Million | -84.38 Million | -1.83 Million |
| Other working capital | 452.1 Million | 232.63 Million | -139.9 Million | 275.54 Million | 314.07 Million | 92.56 Million |
| Cash at beginning of period | 2.29 Billion | 1.31 Billion | 1.69 Billion | 1.08 Billion | 684.78 Million | 999.03 Million |
| Cash at end of period | 2.42 Billion | 2.29 Billion | 1.31 Billion | 1.69 Billion | 1.08 Billion | 684.78 Million |
| Capital Expenditure | -159.52 Million | -80.67 Million | -19.64 Million | -62.2 Million | -26.56 Million | -90.86 Million |
| Effect of forex changes on cash | 51 Thousand | 33 Thousand | 26 Thousand | - | 1000.00 | 1000.00 |
| Net cash flow / Change in cash | 128.97 Million | 983.85 Million | -383.3 Million | 610.96 Million | 400.3 Million | -314.24 Million |
| Free Cash Flow | 626.27 Million | 1.49 Billion | -61.2 Million | 641.17 Million | 296.1 Million | -24.34 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 145 Million | 180 Million | 853.98 Million | 326 Million | 171 Million | 176 Million |
| Depreciation & Amortization | - | - | 174.34 Million | 41.5 Million | 41.86 Million | 41.57 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -90.86 Million | - | - | - |
| Other non-cash items | -145 Million | -180 Million | 739.98 Million | -326 Million | -171 Million | -176 Million |
| Investing Cash Flow | - | - | -146.36 Million | - | - | - |
| Investments in PPE | - | - | -159.52 Million | - | - | - |
| Acquisitions | - | - | 48.88 Million | - | - | - |
| Investment purchases | - | - | -17.7 Million | - | - | - |
| Sales/Maturities of investments | - | - | 49.17 Million | - | - | - |
| Other Investing Activities | - | - | -67.2 Million | - | - | - |
| Financing Cash Flow | - | - | -733.81 Million | - | - | - |
| Debt repayment | - | - | -260.71 Million | - | - | - |
| Dividends payments | - | - | -375.12 Million | - | - | - |
| Common Stock Repurchased | - | - | -33 Thousand | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -17.57 Million | - | - | - |
| Accounts receivables | - | - | -675.99 Million | - | - | - |
| Accounts payables | - | - | 133.02 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 452.1 Million | - | - | - |
| Cash at beginning of period | - | - | 2.29 Billion | 2.13 Billion | 1.94 Billion | 2.29 Billion |
| Cash at end of period | - | - | 2.42 Billion | 2.05 Billion | 2.13 Billion | 1.94 Billion |
| Capital Expenditure | - | - | -159.52 Million | - | - | - |
| Effect of forex changes on cash | - | - | 51 Thousand | - | - | - |
| Net cash flow / Change in cash | - | - | 128.97 Million | -83.33 Million | 188.59 Million | -347.93 Million |
| Free Cash Flow | - | - | 626.27 Million | 83.01 Million | 83.73 Million | 83.14 Million |
VS
LNMG
2337
BIT
PRG
MEDICAPQ